Dilated cardiomyopathy future or investigational therapies

Dilated cardiomyopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Classification
Causes
Differentiating Dilated cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dilated cardiomyopathy future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dilated cardiomyopathy future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dilated cardiomyopathy future or investigational therapies
CDC on Dilated cardiomyopathy future or investigational therapies
Dilated cardiomyopathy future or investigational therapies in the news
Blogs on Dilated cardiomyopathy future or investigational therapies
Directions to Hospitals Treating Dilated cardiomyopathy
Risk calculators and risk factors for Dilated cardiomyopathy future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]

Overview

New promising treatments for dilated cardiomyopathy include -among others- stem cell-based treatments, cholesterol-lowering drugs in combination with angiotensin receptor blockers, and protein A immunoadsorption.

Future or Investigational Therapies

There are several new therapies, currently under investigation for dilated cardiomyopathy. The most promising of these therapies include:

• Stem cell-based treatments: Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC])
• Cholesterol lowering drugs as Simvastatin or rosuvaststin, alone or in combination with angiotensin receptor blockers as valsartan or olmesartan.
• Protein A Immunoadsorption: an extracorporeal technique used for the removal of IgG antibodies and molecules.
• Other drugs under investigation include Qiliqiangxin, Ranolazine, and Benazepril.